Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| U.S. Food and Drug Administration Approves Gilead Sciences' Complera(TM), a ... - MarketWatch (press release) |
 |
 |
|
MarketWatch (press release) New onset or worsening renal impairment Renal impairment, including cases of acute renal failure and Fanconi syndrome (renal tubular injury with severe hypophosphatemia), has been reported with the use of tenofovir disoproxil fumarate. |
